In chronic CD, increased plasma levels of MMP2 predicted early cardiac remodeling in clinically asymptomatic CD, while MMP9 was identified as a risk factor for late fibrosis and severe cardiac remodeling in clinically symptomatic patients (11). The gene discussed is MMP2; the disease is Cowden disease.